Biomedical subjects
F Matzkies
Publications and source records attributed to F Matzkies.
[Procetofen, a new lipid- and urine-acid-reducing substance].
23 patients with different forms of hyperlipidemias received procetofen (3 X 100 mg/day) over a period of fourteen days. The cholesterol concentration in blood showed a significant reduction from 322 +/- 30 mg/dl to 227 +/- 37 mg/dl, triglycerides dropped from 221 +/- 84 mg/dl to 129 +/- 34 mg/dl and uric acid diminished from 6,1 +/- 1,4 mg/dl to 4,6 +/- 0,8 mg/dl.
[Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
In a collective of 3899 out-patients, the effect of uric acid reduction of benzbromarone was tested. Ten days after beginning of treatment, a uric acid concentration of 5.1 to 5.7 mg/100 ml had been obtained. Three months after beginning of therapy, uric acid values were at 4.9 mg/100 ml, independently of age and sex. As side-effects were observed:diarrhoea in 1% (n = 41) of the treated patients, furthermore, 0,8% (n = 31) complained of gastro-intestinal trouble such as pressure over the stomach, nausea, sensation of fullness and epigastric pain. Only in 2 of the 3899 patients (0.05%) the appearance of a renal colic was observed.
[Therapy of obesity. Late results after weight reduction with various initial treatment methods].
Explore the source record for details and available documents.
[Disorders of metabolism following stress and trauma].
Explore the source record for details and available documents.
[Behavior of blood amino acids and fatty acids during complete parenteral hyperalimentation with carbohydrates, amino acids and fats].
Over a period of 12 hours a total amount of 190 g fructose, 190 g glucose, 145 g xylitol, 96 g fat and 99 g amino acids were infused. The utilization of carbohydrate was not diminished despite the high fat load. In addition, the antiketogenic action of carbohydrate was still provable. The nitrogen balance was positive as an indicator of good utilization of amino acids. Therefore, simultaneous administration of a carbohydrate mixture and a fat emulsion as energy sources during application of amino acids is recommended.
[Parenteral feeding].
Explore the source record for details and available documents.
[Cholesterol-lowering activity of a formula diet containing soy proteins, apple pectin and bran].
Explore the source record for details and available documents.
Dietary fiber syndrome as the cause of disease in civilised societies.
Explore the source record for details and available documents.
[Dosage of calcium and phosphate in parenteral feeding].
In a carbohydrate combination solution containing 12.5 mEq/1 calcium and 12 mmol/1 phosphate the concentrations of calcium and phosphate were kept constant during parenteral infusion therapy with carbohydrate, at a rate of 0.5 g/kg/h and amino acids at a rate of 0.1 g/kg/h. Balance for calcium and phosphate was positive. Calcium excretion was slightly above the levels determined in oral nutrition. A slight modification of calcium supplement by changing the concentration of the solution to 10 mEq/1 is suggested.
[Water and mineral balance in refeeding after total fasting].
The water balance and the electrolyte balance were measured in 6 patients after 14 days of total starvation. After fasting a 600 calorie formula diet was given for the whole period. The potassium balance was +32 mval/day and that of sodium +120 mval/day. The total loss of potassium in 14 days was 488 mval and that of sodium only 126 mval. Sodium loss is replaced within one day of refeeding. No replacement of the potassium loss was noticed during the 4 day treatment.
[Hyperuricemia due to therapeutic measures].
Some therapeutic measures cause hyperuricemia, which may require treatment in certain cases. The following may induce hyperuricemia: cytostatic long-term treatment, weight reduction through fasting, antihypertensive treatment with different chlorothiazides but also furosemide and etacrynic acid, anti-tuberculostatic therapy and Parkinson long-term treatment.
[Nutrition after gastrectomy].
Dietary therapy after gastrectomy demands a differentiated approach. In the immediate postoperative phase parenteral nutrition is indicated. If no complications occur, the transition to oral nutrition can soon be made, the basic principle of which is adherence to 6-8 small meals. Since, in our experience, after gastric resections numerous disorders can occur, a carefully controlled diet with the aid of nutrional anamnesis is to be recommended. At the same time substitution of vitamin B12, iron, calcium and pancreatic enzymes is absolutely essential.
[Nutritional planning for a "reasonable" diet].
Explore the source record for details and available documents.
[Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
By treating 16 hyperuricemic patients each with 25 and 50 mg of Benzbromarone a significant decrease of the uric acid concentration in the serum into the normal range is achieved. On the 5th and 6th day after beginning the treatment the dosage of 25 mg of Benzbromarone renders a morning value of 5,3 +/- 1,0 and an evening value of 5,0 +/- 0,9 mg/100 ml. After administration of 50 mg of Benzbromarone there is also prevailing a steady-state behaviour on the 5th and 6th day for the uric acid concentration in the serum. Thereby the morning value is 3,7 +/- 0,8 mg/100 ml and th evening value 3,4 +/- 0,9 mg/100 ml. After both dosages an increased urate elimination occurs initially during the 1st, 2nd and 3rd day after beginning of the therapy. However, after having achieved therapeutically reduced uric acid levels, the uric acid elimination from the 4th, 5th and 6th day partially ranges below those values existing before beginning of the therapy. During a chronic treatment no hyperuraturia can be observed on account of the therapeutically reduced serum concentrations. Consequently an increased risk towards a formation of urate calculi is not given under the long-term treatment.
[Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].
After oral application of 100mg of Benzbromarone a significant decrease of the uric acid concentration in the serum up to the 14th day after beginning of the treatment to a mean value of 1,7 mg/100 ml is achieved; while the application of 50 mg of Benzbromarone reduces the uric acid concentration only to a value of 3,4 mg/100 ml. Thereby the differences amounts to about 1,7 mg/100 ml. The urate elimination increases after 100 as well as after 50 mg of Benzbromarone. Only initially an increased uric acid elimination could be observed. In the further course the uric acid elimination remains increased despite reduced serum concentrations.
The uricosuric action of amino acids in man.
Explore the source record for details and available documents.
[Potassium substitution in fasting].
Twenty patients, divided in two groups to ten were undergoing a fasting period for 14 days. One group received 80 mEq potassium per day. Despite of identical loss of body-weight, the application of potassium showed the following advantages: 1) The body is able to keep acid-base-balance. 2) The important loss of potassium, induced by starvation can be reduced to a minimum.